CCNE1 and inflammatory breast carcinoma: In our cohort of 2510 non-IBC patients, 11% of the samples had no cyclin E staining, 28% had nuclear positivity, 23% had nuclear and cytoplasmic positivity, and 38% had cytoplasmic staining (Figure 1A, 1C).